<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04480671</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY19110286</org_study_id>
    <nct_id>NCT04480671</nct_id>
  </id_info>
  <brief_title>Impact of Level III Support Procedure on Enlarged Genital Hiatus After Minimally Invasive Sacrocolpopexy</brief_title>
  <acronym>MERIT</acronym>
  <official_title>Impact of Level III Support Procedure on Normalization of Enlarged Genital Hiatus After Minimally Invasive Sacrocolpopexy: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled surgical trial evaluating the use of a concomitant posterior
      colporrhaphy and/or perineorrhaphy at the conclusion of minimally invasive sacrocolpopexy to
      narrow enlarged genital hiatuses in a population of women with pelvic organ prolapse. The
      study's primary outcome is the proportion of women at 6 months postoperatively who still have
      an enlarged genital hiatus.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 14, 2020</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Postoperative pelvic exams measuring anatomic recurrence of pelvic organ prolapse will be performed by a qualified examiner masked to the original surgery randomization.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Enlarged Genital Hiatus at 6 months postoperatively</measure>
    <time_frame>6 months postoperatively</time_frame>
    <description>Proportion of subjects with enlarged genital hiatus on pelvic exam</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite prolapse recurrence</measure>
    <time_frame>12 months</time_frame>
    <description>Any anatomic prolapse recurrence beyond the hymen, symptomatic on questionnaire, or retreatment for prolapse with surgery or pessary.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective prolapse recurrence</measure>
    <time_frame>24 months</time_frame>
    <description>Any symptomatic recurrence of prolapse on questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspareunia postoperatively</measure>
    <time_frame>6, 12 months postoperatively</time_frame>
    <description>Incidence of dyspareunia, ascertained with the use of a validated questionnaire for sexual function [the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR)].</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual Function postoperatively</measure>
    <time_frame>6, 12 months postoperatively</time_frame>
    <description>Assessment of sexual function, ascertained with the use of a validated questionnaire for sexual function [the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR)].</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Floor Distress Inventory Change</measure>
    <time_frame>baseline, 6, 12 months postoperatively</time_frame>
    <description>Measurement of pelvic floor distress change, using the PFDI-20 which is a validated questionnaire used for pelvic floor disorders and their impact on patient quality of life.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">94</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Sacrocolpopexy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This group will only receive the sacrocolpopexy for their pelvic organ prolapse repair.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sacrocolpopexy and concomitant level III support procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This randomized group will receive an additional vaginal repair for level III support at the conclusion of the sacrocolpopexy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Level III support procedure</intervention_name>
    <description>A level III support procedure is aimed at repairing the distal support of the vagina with either a posterior colporrhaphy and/or a perineorrhaphy.</description>
    <arm_group_label>Sacrocolpopexy and concomitant level III support procedure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimally Invasive Sacrocolpopexy</intervention_name>
    <description>All study participants are planning with their surgeon a minimally invasive sacrocolpopexy (robotic or laparoscopic) to repair pelvic organ prolapse.</description>
    <arm_group_label>Sacrocolpopexy</arm_group_label>
    <arm_group_label>Sacrocolpopexy and concomitant level III support procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female subjects with pelvic organ prolapse (POP)

          -  Planning a surgical repair of POP with minimally invasive sacrocolpopexy

          -  Preoperative resting genital hiatus measure between 4.0 and 7.5cm

        Exclusion Criteria: subjects who are unable to complete questionnaires or repeat office
        exams or if they do not otherwise meet inclusion criteria above

        *Note: we will NOT exclude patients based on prior surgical history (including prior
        posterior colporrhaphy)*
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bradley MS, Askew AL, Vaughan MH, Kawasaki A, Visco AG. Robotic-assisted sacrocolpopexy: early postoperative outcomes after surgical reduction of enlarged genital hiatus. Am J Obstet Gynecol. 2018 May;218(5):514.e1-514.e8. doi: 10.1016/j.ajog.2018.01.046. Epub 2018 Feb 6.</citation>
    <PMID>29425837</PMID>
  </reference>
  <reference>
    <citation>Nosti PA, Umoh Andy U, Kane S, White DE, Harvie HS, Lowenstein L, Gutman RE. Outcomes of abdominal and minimally invasive sacrocolpopexy: a retrospective cohort study. Female Pelvic Med Reconstr Surg. 2014 Jan-Feb;20(1):33-7. doi: 10.1097/SPV.0000000000000036.</citation>
    <PMID>24368486</PMID>
  </reference>
  <reference>
    <citation>Siddiqui NY, Geller EJ, Visco AG. Symptomatic and anatomic 1-year outcomes after robotic and abdominal sacrocolpopexy. Am J Obstet Gynecol. 2012 May;206(5):435.e1-5. doi: 10.1016/j.ajog.2012.01.035. Epub 2012 Feb 1.</citation>
    <PMID>22397900</PMID>
  </reference>
  <reference>
    <citation>Kahn MA, Stanton SL. Posterior colporrhaphy: its effects on bowel and sexual function. Br J Obstet Gynaecol. 1997 Jan;104(1):82-6.</citation>
    <PMID>8988702</PMID>
  </reference>
  <reference>
    <citation>Vaughan MH, Siddiqui NY, Newcomb LK, Weidner AC, Kawasaki A, Visco AG, Bradley MS. Surgical Alteration of Genital Hiatus Size and Anatomic Failure After Vaginal Vault Suspension. Obstet Gynecol. 2018 Jun;131(6):1137-1144. doi: 10.1097/AOG.0000000000002593.</citation>
    <PMID>29742664</PMID>
  </reference>
  <reference>
    <citation>Carter-Brooks CM, Lowder JL, Du AL, Lavelle ES, Giugale LE, Shepherd JP. Restoring Genital Hiatus to Normative Values After Apical Suspension Alone Versus With Level 3 Support Procedures. Female Pelvic Med Reconstr Surg. 2019 May/Jun;25(3):226-230. doi: 10.1097/SPV.0000000000000528.</citation>
    <PMID>29210807</PMID>
  </reference>
  <reference>
    <citation>Sutkin G, Zyczynski HM, Sridhar A, Jelovsek JE, Rardin CR, Mazloomdoost D, Rahn DD, Nguyen JN, Andy UU, Meyer I, Gantz MG; NICHD Pelvic Floor Disorders Network. Association between adjuvant posterior repair and success of native tissue apical suspension. Am J Obstet Gynecol. 2020 Feb;222(2):161.e1-161.e8. doi: 10.1016/j.ajog.2019.08.024. Epub 2019 Aug 23.</citation>
    <PMID>31449806</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 17, 2019</study_first_submitted>
  <study_first_submitted_qc>July 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2020</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Stephanie Glass Clark</investigator_full_name>
    <investigator_title>Fellow, Female Pelvic Medicine and Reconstructive Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make IPD available to other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

